Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
produce registration-enabling data.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 CAD | -0.70% | -1.40% | -21.23% |
1st Jan change | Capi. | |
---|---|---|
-21.23% | 78.27M | |
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |